From multiplex serology to serolomics – a novel approach to the antibody response against the SARS-CoV-2 proteome
Author:
Butt Julia,Murugan Rajagopal,Hippchen Theresa,Olberg Sylvia,van Straaten Monique,Wardemann Hedda,Stebbins Erec,Kräusslich Hans-Georg,Bartenschlager Ralf,Brenner Hermann,Laketa Vibor,Schöttker Ben,Müller Barbara,Merle Uta,Waterboer Tim
Abstract
ABSTRACTBackgroundThe emerging SARS-CoV-2 pandemic entails an urgent need for specific and sensitive high-throughput serological assays to assess SARS-CoV-2 epidemiology. We therefore aimed at developing a fluorescent-bead based SARS-CoV-2 multiplex serology assay for detection of antibody responses to the SARS-CoV-2 proteome.MethodsProteins of the SARS-CoV-2 proteome and protein N of SARS-CoV-1 and common cold Coronaviruses (ccCoVs) were recombinantly expressed inE. colior HEK293 cells. Assay performance was assessed in a Covid-19 case cohort (n=48 hospitalized patients from Heidelberg) as well as n=85 age- and sex-matched pre-pandemic controls from the ESTHER study. Assay validation included comparison with home-made immunofluorescence and commercial Enzyme-linked immunosorbent (ELISA) assays.ResultsA sensitivity of 100% (95% CI: 86%-100%) was achieved in Covid-19 patients 14 days post symptom onset with dual sero-positivity to SARS-CoV-2 N and the receptor-binding domain of the spike protein. The specificity obtained with this algorithm was 100% (95% CI: 96%-100%). Antibody responses to ccCoVs N were abundantly high and did not correlate with those to SARS-CoV-2 N. Inclusion of additional SARS-CoV-2 proteins as well as separate assessment of immunoglobulin (Ig) classes M, A, and G allowed for explorative analyses regarding disease progression and course of antibody response.ConclusionThis newly developed SARS-CoV-2 multiplex serology assay achieved high sensitivity and specificity to determine SARS-CoV-2 sero-positivity. Its high throughput ability allows epidemiologic SARS-CoV-2 research in large population-based studies. Inclusion of additional pathogens into the panel as well as separate assessment of Ig isotypes will furthermore allow addressing research questions beyond SARS-CoV-2 sero-prevalence.
Publisher
Cold Spring Harbor Laboratory
Reference27 articles.
1. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?;Int J Infect Dis,2020 2. Becker, M. , Strengert, M. , Junker, D. , Kerrinnes, T. , Kaiser, P.D. , Traenkle, B. , Dinter, H. , Haering, J. , Zeck, A. , Weise, F. , et al. (2020). Going beyond clinical routine in SARS-CoV-2 antibody testing - A multiplex corona virus antibody test for the evaluation of cross-reactivity to endemic coronavirus antigens. medRxiv, 2020.2007.2017.20156000. 3. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value;International journal of cancer Journal international du cancer,2007 4. Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence;International journal of cancer Journal international du cancer,2016 5. Dao Thi, V.L. , Herbst, K. , Boerner, K. , Meurer, M. , Kremer, L.P. , Kirrmaier, D. , Freistaedter, A. , Papagiannidis, D. , Galmozzi, C. , Stanifer, M.L. , et al. (2020). A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples. Sci Transl Med 12.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|